Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in RPRX — Royalty Pharma plc

CIK 873630 LONDON, X0
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$68,681,542
-$5,384,999 QoQ
Shares Held
1,224,925
-20.7% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#49
of 646 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. RPRX ranks #4 (5.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 676,247 $335,912,169
2 REGN
Regeneron Pharmaceuticals, Inc.
 382,028 $238,209,735
3 INCY
Incyte Corp
 1,307,743 $148,245,744
4 RPRX
Royalty Pharma plc
This page 		1,224,925 $68,681,542
5 MRNA
Moderna, Inc.
 636,199 $44,553,014
6 ALNY
Alnylam Pharmaceuticals, Inc.
 115,279 $34,702,435
7 INSM
INSMED Inc
 279,961 $29,849,438
8 BMRN
Biomarin Pharmaceutical Inc
 307,543 $17,597,610

All Filings in RPRX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $68,681,542 1,224,925
2026-03-31 $74,066,541 1,544,018
2025-12-31 $2,241,041 57,998
2025-09-30 $8,456,898 239,708
2025-06-30 $1,307,889 36,300
2025-03-31 $3,542,531 113,798
2024-12-31 $4,395,781 172,316
2024-09-30 $5,732,119 202,620
2024-06-30 $13,839,345 524,814
2024-03-31 $28,075,030 924,433
2023-12-31 $4,080,634 145,270
2023-09-30 $3,646,991 134,377
2023-06-30 $4,079,044 132,695
2023-03-31 $904,497 25,104
2022-12-31 $30,634,995 775,177
2022-09-30 $18,745,014 466,526
2022-06-30 $9,837,023 233,992
2021-09-30 $945,566 26,164
2021-06-30 $694,657 16,947
2020-12-31 $917,967 18,341
2020-09-30 $253,850 6,034